CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

CareFirst BlueCross BlueShield

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
C
Index (ASP = 100)
99.9
Vs. acquisition
-2.8%
Brand index
99.8
Biosimilar index
104.2
Contract variability
Low
Drugs observed
880
States
19

Contracts below the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 3 distinct contracted rates across practices, with 94% of billing volume on the single most common rate — a card system — a few standard rates, most practices on the standard one.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.